Efficiency of periodontal treatment to improve type 2 diabetes mellitus outcomes: A systematic review and meta-analysis of economic evaluations.

IF 1.8 3区医学 Q2 DENTISTRY, ORAL SURGERY & MEDICINE Community dentistry and oral epidemiology Pub Date : 2024-08-16 DOI:10.1111/cdoe.12999

Gustavo Sáenz-Ravello, Marianela Castillo-Riquelme, Cristóbal Cuadrado, Jorge Gamonal, Mauricio Baeza

{"title":"Efficiency of periodontal treatment to improve type 2 diabetes mellitus outcomes: A systematic review and meta-analysis of economic evaluations.","authors":"Gustavo Sáenz-Ravello, Marianela Castillo-Riquelme, Cristóbal Cuadrado, Jorge Gamonal, Mauricio Baeza","doi":"10.1111/cdoe.12999","DOIUrl":null,"url":null,"abstract":"Background: To assess the efficiency of periodontal treatment (PT) in improving diabetes-related outcomes in adults with type 2 diabetes mellitus (T2DM) and periodontitis, providing an updated and comprehensive synthesis from economic evaluations (EE).Methods: Seven databases and one register were independently searched by two reviewers for articles published up to 8 May 2024. Studies that assessed the efficiency of PT versus no treatment or other dental treatments were included. Risk of bias was assessed using the Cochrane RoB 2, ROBINS-I and ECOBIAS tools for the first stage of EE and the CHEERS checklist and NICE quality appraisal tool for overall EE. Qualitative and quantitative syntheses of the articles were conducted and assessed using the GRADE approach.Results: Eleven studies were included. PT reduces total healthcare costs, including inpatient and outpatient, diabetes-related costs and other drug costs (low to moderate certainty). A total incremental net benefit of USD 12 348 (2022 currency, 95% CI 12 195-12 500) was estimated from three high-quality model-based cost-utility analyses (high certainty).Discussion: The inclusion of PT in the comprehensive treatment of patients with T2DM and periodontitis is cost-effective. Future research is required to ensure the transferability of these findings and inform decision makers from different countries.Registration: PROSPERO CRD42023443146.","PeriodicalId":10580,"journal":{"name":"Community dentistry and oral epidemiology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community dentistry and oral epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cdoe.12999","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Background: To assess the efficiency of periodontal treatment (PT) in improving diabetes-related outcomes in adults with type 2 diabetes mellitus (T2DM) and periodontitis, providing an updated and comprehensive synthesis from economic evaluations (EE).

Methods: Seven databases and one register were independently searched by two reviewers for articles published up to 8 May 2024. Studies that assessed the efficiency of PT versus no treatment or other dental treatments were included. Risk of bias was assessed using the Cochrane RoB 2, ROBINS-I and ECOBIAS tools for the first stage of EE and the CHEERS checklist and NICE quality appraisal tool for overall EE. Qualitative and quantitative syntheses of the articles were conducted and assessed using the GRADE approach.

Results: Eleven studies were included. PT reduces total healthcare costs, including inpatient and outpatient, diabetes-related costs and other drug costs (low to moderate certainty). A total incremental net benefit of USD 12 348 (2022 currency, 95% CI 12 195-12 500) was estimated from three high-quality model-based cost-utility analyses (high certainty).

Discussion: The inclusion of PT in the comprehensive treatment of patients with T2DM and periodontitis is cost-effective. Future research is required to ensure the transferability of these findings and inform decision makers from different countries.

Registration: PROSPERO CRD42023443146.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

牙周治疗改善 2 型糖尿病疗效的效率：经济评估的系统回顾和荟萃分析。

背景：评估牙周治疗（PT）在改善患有2型糖尿病（T2DM）和牙周炎的成人的糖尿病相关预后方面的效率，提供经济评估（EE）的最新综合结果：方法：两位审稿人独立检索了七个数据库和一个登记册，以查找截至 2024 年 5 月 8 日发表的文章。纳入了评估牙周治疗与不治疗或其他牙科治疗效果的研究。使用Cochrane RoB 2、ROBINS-I和ECOBIAS工具对EE第一阶段进行偏倚风险评估，使用CHEERS检查表和NICE质量评估工具对整体EE进行偏倚风险评估。对文章进行了定性和定量综合，并采用 GRADE 方法进行评估：结果：共纳入 11 项研究。PT 可降低总医疗费用，包括住院和门诊费用、糖尿病相关费用及其他药物费用（低度至中度确定性）。根据三项高质量的基于模型的成本效用分析（高度确定性），估计总增量净效益为12 348美元（2022年货币，95% CI 12 195-12 500）：讨论：将牙周治疗纳入 T2DM 和牙周炎患者的综合治疗具有成本效益。讨论：将牙周治疗纳入 T2DM 和牙周炎患者的综合治疗具有成本效益。未来需要开展研究，以确保这些研究结果的可移植性，并为不同国家的决策者提供信息：PROPERCO CRD42023443146.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Community dentistry and oral epidemiology 医学-公共卫生、环境卫生与职业卫生

CiteScore

4.40

自引率

8.70%

发文量

审稿时长

6 months

期刊介绍： The aim of Community Dentistry and Oral Epidemiology is to serve as a forum for scientifically based information in community dentistry, with the intention of continually expanding the knowledge base in the field. The scope is therefore broad, ranging from original studies in epidemiology, behavioral sciences related to dentistry, and health services research through to methodological reports in program planning, implementation and evaluation. Reports dealing with people of all age groups are welcome. The journal encourages manuscripts which present methodologically detailed scientific research findings from original data collection or analysis of existing databases. Preference is given to new findings. Confirmations of previous findings can be of value, but the journal seeks to avoid needless repetition. It also encourages thoughtful, provocative commentaries on subjects ranging from research methods to public policies. Purely descriptive reports are not encouraged, nor are behavioral science reports with only marginal application to dentistry. The journal is published bimonthly.